Harvard 5th Annual Update in Neuro-Oncology 2025
Original price was: $720.00.$49.00Current price is: $49.00.
4.9
(44 reviews)
Harvard Medical School’s definitive 3-day neuro-oncology update — 40 expert sessions covering pediatric & adult CNS tumors, WHO classification, experimental glioma therapies, live tumor boards, and neurological complications of cancer.
61 viewing now
🔥 Bestseller
Secure payment via
| 🔒 Secure Checkout |
↩️ 30-Day Refund |
♾️ Lifetime Access |
✅ Instant Download |
🎓 HARVARD MEDICAL SCHOOL · CME ACCREDITED · 3-DAY COURSE · ON-DEMAND 2025
5th Annual Update in Neuro-Oncology 2025
The most comprehensive Harvard neuro-oncology update — covering pediatric and adult CNS/PNS tumors, WHO classification, experimental therapies, live tumor board discussions, and neurological complications of cancer. Taught by Harvard Medical School’s leading faculty.
⚡ Instant Digital Access — Google Drive
Includes: 40 HD Videos (.mp4) + 1 Comprehensive PDF · Total Size: 5.78 GB · Lifetime Access
40
HD Video Sessions
3
Live Tumor Boards
5.78 GB
Total Content
35+
HMS Faculty
📚 Course Overview
Neuro-oncology is a rapidly evolving multi-disciplinary field involving the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the CNS and PNS — encompassing neurogenetic syndromes, neurological complications of cancer, and essential molecular neuropathology and neuroradiology concepts.
The 5th Annual Harvard Update in Neuro-Oncology delivers a comprehensive 3-day CME curriculum — from WHO classification updates and pediatric gliomas to experimental therapies, live CNS tumor boards, and managing neurological complications of immunotherapy.
“The caliber of the faculty is unmatched. Getting to hear directly from the leaders writing the WHO classification guidelines was a highlight.” — Neuropathologist, 2024 Attendee
🎯 Learning Objectives
Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
Recognize and manage neurological complications associated with new cancer therapies including immunotherapy.
Describe and manage long-term complications of CNS and PNS tumors and their treatment, including survivorship care.
📋 3-Day Course Agenda
July 23–25, 2025 · Harvard Medical School · 40 Sessions across 3 Full Days
Day 1 — Wednesday, July 23 · 🧒 Pediatric Neuro-Oncology
Sanda Alexandrescu
Tina Young Poussaint
Susan Chi · Pratiti Bandopadhayay · Mariella Filbin
Karen Wright · Shannon MacDonald · Kee Kiat Yeo
Justin Jordan · Othon Iliopoulos
Mariella Filbin · Ralph Salloum
Day 2 — Thursday, July 24 · 🧠 Adult Neuro-Oncology
Chiocca · Huang · Marciscano
Maria Martinez-Lage Alvarez
Gonzalez Castro · Arrillaga-Romany
David Reardon
Bi · Batchelor · Jones
L. Nicolas Gonzalez Castro
Day 3 — Friday, July 25 · 💊 Neurological Complications of Cancer
Brastianos · Wang · John Chi
David Gritsch
Jorg Dietrich
Deborah Forst
Annie Hsieh
👨⚕️ Course Directors & Distinguished Faculty
35+ Harvard Medical School faculty — including the leaders who write the WHO classification guidelines.
Tracy Batchelor, MD, MPH
COURSE DIRECTOR
Neurologist-in-Chief, Mass General Brigham · Martin A. Samuels Professor, HMS
E. Antonio Chiocca, MD, PhD
COURSE DIRECTOR
Neurosurgeon-in-Chief, Brigham & Women’s Hospital · Harvey W. Cushing Professor, HMS
Patrick Wen, MD
COURSE DIRECTOR
Director, Center for Neuro-Oncology, Dana-Farber · Professor of Neurology, HMS
35+ Participating HMS Faculty include:
Priscilla Brastianos · David Reardon · Mariella Filbin · Wenya Linda Bi · L. Nicolas Gonzalez Castro · Jorg Dietrich · Raymond Huang · Sanda Alexandrescu · Justin Jordan · Tina Young Poussaint · Deborah Forst · Maria Martinez-Lage Alvarez · and 20+ more Harvard specialists.
🎯 Who Should Attend?
Oncologists
Radiation Oncologists
Neurosurgeons
Neuroradiologists
Neuropathologists
Pediatric Oncologists
Nurse Practitioners
Physician Assistants
⭐ What Attendees Say
“An incredible update on the latest in neuro-oncology. The live tumor board discussions were incredibly valuable and translated directly to my daily practice.”
Clinical Neurologist — 2024 Attendee
“The caliber of the faculty is unmatched. Getting to hear directly from the leaders writing the WHO classification guidelines was a highlight.”
Neuropathologist — 2024 Attendee
“A brilliantly organized course. The balance between pediatric and adult neuro-oncology gave me a well-rounded perspective.”
Medical Oncologist — 2023 Attendee
🔒 CME Accredited · Harvard Medical School · 5.78 GB · Lifetime Access
Think Deeper. Treat Better.
Join oncologists and neurologists mastering neuro-oncology with Medicalosa.
